Accardi Mario Alberto

Insider·Centessa Pharmaceuticals plc·CNTA·Insider since 2025·Form 4 filings: 9
Trades YTD
0
Trades (12m)
9
Net position
Current holdings
P-code buys (12m)
0
Cluster
None

Transaction history · last 12 months

9 transactions
09 Dec 2025
SOLD
$CNTA
2,568
$29.21
S
09 Dec 2025
SOLD
$CNTA
7,432
$28.70
S
08 Dec 2025
SOLD
$CNTA
10,000
$30.00
S
27 Oct 2025
SOLD
$CNTA
8,000
$25.00
S
16 Sep 2025
SOLD
$CNTA
742
$22.02
S
16 Sep 2025
SOLD
$CNTA
7,430
$21.33
S
09 Sep 2025
SOLD
$CNTA
7,000
$20.00
S
29 Jul 2025
SOLD
$CNTA
8,322
$15.23
S
24 Jun 2025
SOLD
$CNTA
15,000
$14.00
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · Centessa Pharmaceuticals plc

last 30 days

No active insider cluster at Centessa Pharmaceuticals plc in the last 30 days. Alberto's recent transactions appear in the section above.

Convergence · Pattern Engine ships in v1.1

30-day window
In development

Convergence participation lands with the Pattern Engine.

Once the Pattern Engine ships, this section will list every active convergence event Alberto is named in — the hedge funds and Congress members on the same name, the 30-day window, and the combined position size.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 06:13 UTC.